Syed Bahaudddin Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Syed Bahaudddin Shah has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Khalida Unar
Institute of microbiology Shah Abdul Latif University Khairpur Sindh Pakistan
1 shared publication - Muhammad Suleman Ejaz
MBBS Graduate University of Health Sciences Pakistan
1 shared publication - Rabia Jaffar
Currently Working in Acute Medicine NHS MBBS MRCP(UK UK
1 shared publication - Sri Pranita Cherukuri
MBBS MPH Columbia University New York United States
1 shared publication - Tariq Rafique
Medical Affairs, Dadabhoy Institute of Higher Education, Karachi, PAK
1 shared publication
Latest Publications
- Open Access
- 25 September 2024
- Published by Green Publication
- Vol. 31 (9) , 1766-1774
GENETIC INSIGHTS INTO THYROID TUMOR PROGRESSION: FROM ADENOMA TO ANAPLASTIC CANCER
Background: Thyroid neoplasms exhibit a diverse evolutionary trajectory, suggesting distinct pathways from normal thyroid cells to malignancy. Methods: Molecular changes initiating follicular adenoma formation likely precede progression to follicular cancer. Papillary carcinoma, however, may evolve via a separate pathway, bypassing follicular adenoma. Subsequent genetic alterations can lead to anaplastic cancer, significantly impacting prognosis. Results: Genome instability predisposes thyroid tumour cells to molecular alterations, with proto-oncogene changes occurring early and suppressor gene mutations typically occurring later. These changes contribute to aggressive or invasive behaviours, potentially influencing clinical outcomes. Conclusion: Advances in understanding genetic alterations in thyroid oncogenesis offer promise for enhancing diagnostic accuracy and treatment efficacy, thereby improving outcomes for thyroid malignancies.
- 25 September 2024
- Published by Green Publication
- Vol. 31 (9) , 1766-1774
Open AccessGENETIC INSIGHTS INTO THYROID TUMOR PROGRESSION: FROM ADENOMA TO ANAPLASTIC CANCER
Background: Thyroid neoplasms exhibit a diverse evolutionary trajectory, suggesting distinct pathways from normal thyroid cells to malignancy. Methods: Molecular changes initiating follicular adenoma formation likely precede progression to follicular cancer. Papillary carcinoma, however, may evolve via a separate pathway, bypassing follicular adenoma. Subsequent genetic alterations can lead to anaplastic cancer, significantly impacting prognosis. Results: Genome instability predisposes thyroid tumour cells to molecular alterations, with proto-oncogene changes occurring early and suppressor gene mutations typically occurring later. These changes contribute to aggressive or invasive behaviours, potentially influencing clinical outcomes. Conclusion: Advances in understanding genetic alterations in thyroid oncogenesis offer promise for enhancing diagnostic accuracy and treatment efficacy, thereby improving outcomes for thyroid malignancies.